Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human Thrombopoietin/Tpo Antibody, R&D Systems™

Goat Polyclonal Antibody has been used in 2 publications
Supplier: R&D Systems AF288SP
This item is not returnable.
View return policy
Description
Thrombopoietin/THPO Polyclonal specifically detects Thrombopoietin/THPO in Human samples. It is validated for Western Blot, Neutralization.Specifications
Thrombopoietin/Tpo | |
Polyclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
Megakaryocyte colony-stimulating factor, Megakaryocyte growth and development factor, megakaryocyte stimulating factor, MGDF, MGDFC-mpl ligand, MKCSF, MK-CSF, ML, MPL ligand, MPLLG, MPLLGMGC163194, Myeloproliferative leukemia virus oncogene ligand, THCYT1, THPO, thrombopoietin, thrombopoietin nirs variant 1, Tpo, TPOMKCSF | |
Goat | |
Affinity Purified | |
RUO | |
7066 | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Western Blot, Neutralization | |
LYOPH | |
Western Blot 0.1 ug/mL, Neutralization 0.05-0.3 ug/mL | |
P40225 | |
THPO | |
S. frugiperda insect ovarian cell line Sf 21-derived recombinant human Tpo Ser22-Gly353 Accession # P40225 | |
25 μg | |
Primary | |
Detects human Tpo in direct ELISAs and Western blots. In direct ELISAs, less than 10% cross-reactivity with recombinant mouse Tpo and recombinant rat Tpo is observed. | |
Human | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction